CACNB3
Overview
flowchart TD
classDef gene fill:#0a1f0a,stroke:#4caf50,color:#e0e0e0
classDef protein fill:#0a1929,stroke:#2196f3,color:#e0e0e0
classDef disease fill:#2d0f0f,stroke:#e91e63,color:#e0e0e0
classDef pathway fill:#3e2200,stroke:#ff9800,color:#e0e0e0
classDef mechanism fill:#1a0a1f,stroke:#9c27b0,color:#e0e0e0
classDef therapeutic fill:#e0f2f1,stroke:#009688,color:#0d0d1a
CACNB3["CACNB3"] -->|"implicated_in"| neurodegeneration["neurodegeneration"]
CACNB3["CACNB3"] -->|"associated_with"| Ca_v_1_4["Ca(v)1.4"]
CACNB3["CACNB3"] -->|"binds"| Kir_Gem["Kir/Gem"]
CACNB3["CACNB3"] -->|"participates_in"| CACNA1C["CACNA1C"]
CACNB3["CACNB3"] -->|"associated_with"| Plasma_membrane["Plasma membrane"]
CACNB3["CACNB3"] -->|"associated_with"| Mesial_Temporal_Lobe_Epilepsy["Mesial Temporal Lobe Epilepsy"]
CACNB3["CACNB3"] -->|"associated_with"| Blood_Brain_Barrier["Blood-Brain Barrier"]
CACNB3["CACNB3"] -->|"regulates"| Insulin_Expression["Insulin Expression"]
CACNB3["CACNB3"] -->|"associated_with"| ADRB1["ADRB1"]
CACNB3["CACNB3"] -->|"therapeutic_target"| AGING["AGING"]
CACNB3["CACNB3"] -->|"associated_with"| CPT2["CPT2"]
CACNB3["CACNB3"] -->|"associated_with"| CPT1A["CPT1A"]
CACNB3["CACNB3"] -->|"associated_with"| CACNA2D2["CACNA2D2"]
CACNB3["CACNB3"] -->|"associated_with"| Rb["Rb"]
hsa_miR_34a_5p["hsa-miR-34a-5p"] -->|"regulates"| CACNB3["CACNB3"]
CDH1["CDH1"] -->|"therapeutic_target"| CACNB3["CACNB3"]
PER["PER"] -->|"therapeutic_target"| CACNB3["CACNB3"]
...CACNB3
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">CACNB3</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CACNB3</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CACNB3</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=CACNB3" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/mesial-temporal-lobe-epilepsy" style="color:#ef9a9a">Mesial Temporal Lobe Epilepsy</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>
CACNB3 encodes the voltage-gated calcium channel beta-3 auxiliary subunit (CaVbeta3), a cytosolic component that binds the alpha1 channel complex and governs trafficking, surface expression, and gating behavior of multiple high-voltage-activated calcium channels.[@buraei2010][@dolphin2012] Because calcium-entry dynamics are central to synaptic signaling, mitochondrial stress, and excitotoxic vulnerability, CACNB3 is mechanistically relevant to neurodegeneration even where direct monogenic causality is limited.[@dolphin2012][@bezprozvanny2008]
In translational terms, CACNB3 is best interpreted as a channel-complex regulator that can shape disease trajectory through calcium-load control in vulnerable circuits.
Molecular And Biophysical Role
CaVbeta subunits (beta1-beta4) bind the alpha-interaction domain on the channel alpha1 subunit and modulate:
- Channel trafficking to the plasma membrane.
- Voltage-dependent activation/inactivation profiles.
- Current density and recovery kinetics under repetitive firing.[@buraei2010][@dolphin2012]
For CACNB3 specifically, the subunit contributes to context-specific tuning across neuronal and endocrine tissues and may alter how cells respond to sustained depolarizing stress.[@dolphin2012][@zamponi2015]
Circuit-Level Relevance
Calcium channels regulate neurotransmitter release, dendritic excitability, gene-expression coupling, and activity-dependent plasticity. Through channel-complex regulation, CACNB3 can influence:
- Synaptic reliability in high-frequency networks.
- Calcium-dependent transcriptional responses to chronic stress.
- Thresholds for maladaptive plasticity and excitotoxic signaling.[@bezprozvanny2008][@catterall2011]
This places CACNB3 within mechanistic proximity to [calcium dysregulation in Alzheimer\'s disease](/mechanisms/calcium-dysregulation-alzheimers), as well as broader signaling nodes including [MAPK-ERK](/mechanisms/mapk-erk-signaling-pathway-neurodegeneration) and [PI3K-AKT-mTOR](/mechanisms/pi3k-akt-mtor-signaling-pathway-neurodegeneration).
Neurodegeneration-Relevant Mechanisms
1. Calcium Overload And Energetic Stress
[Neurons](/entities/neurons) under proteostatic or inflammatory stress are less tolerant of prolonged calcium influx. Auxiliary-subunit composition can shift channel behavior and therefore cumulative calcium burden, affecting mitochondrial resilience and [ROS](/entities/reactive-oxygen-species) generation.[@bezprozvanny2008][@supnet2010]
2. Synaptic Failure Progression
Early synaptic dysfunction is a hallmark across AD, PD, and FTD spectra. CACNB3-mediated tuning of presynaptic and dendritic calcium handling can act as a modifier of synaptic decline rate.[@catterall2011][@supnet2010]
3. Neuroinflammatory Amplification Context
Inflammatory signaling can alter channel expression programs and excitability set points. In this environment, CACNB3-related channel-complex changes may influence vulnerability to secondary degeneration.[@surmeier2017][@eroglu2009]
Disease-Domain Interpretation
Alzheimer Spectrum
Calcium dyshomeostasis is a major AD mechanism. CACNB3 is not a principal AD risk gene, but its role in channel-complex behavior makes it biologically plausible as a progression modifier and a systems-level vulnerability factor.[@bezprozvanny2008][@supnet2010]
Parkinsonian Disorders
Motor and cognitive circuit function relies on tightly controlled calcium signaling. Channel-subunit balance, including beta subunits, may shape susceptibility to firing-pattern dysregulation and calcium-dependent stress in dopamine-linked networks.[@catterall2011][@surmeier2017]
Broader Neuropsychiatric And Seizure Overlap
Calcium-channel auxiliary-subunit variation has been studied in epilepsy and psychiatric phenotypes. These overlaps are relevant because network hyperexcitability and cognitive instability can accelerate neurodegenerative decline in susceptible patients.[@zamponi2015][@eroglu2009]
Therapeutic And Biomarker Positioning
CACNB3 is currently a network-modifier target class rather than a direct drug target with clinical-grade selectivity. Near-term translational opportunities include:
- Multi-omic stratification to identify CACNB3-linked excitability endophenotypes.
- Integration with electrophysiologic biomarkers (oscillatory instability, state transitions).
- Combination strategy modeling with therapies that reduce calcium load or enhance mitochondrial buffering.
Given widespread calcium-channel biology across tissues, precision targeting must balance CNS efficacy with cardiovascular and endocrine safety constraints.[@buraei2010][@dolphin2012]
Priority Research Directions
- Single-cell and spatial transcriptomic mapping of CACNB3 in vulnerable cortical, hippocampal, and brainstem populations.
- Channel-complex proteomics in iPSC-derived neuronal models carrying AD/PD risk backgrounds.
- Longitudinal association studies linking CACNB3 expression states to progression and treatment response.
See Also
- [Calcium Dysregulation in Alzheimer\'s Disease](/mechanisms/calcium-dysregulation-alzheimers)
- [MAPK-ERK Signaling Pathway in Neurodegeneration](/mechanisms/mapk-erk-signaling-pathway-neurodegeneration)
- [Neuroinflammation Pathway in Neurodegeneration](/mechanisms/neuroinflammation-pathway-neurodegeneration)
External Links
- [NCBI Gene: cacnb3](https://www.ncbi.nlm.nih.gov/gene/)
- [PubMed: cacnb3](https://pubmed.ncbi.nlm.nih.gov/?term=cacnb3+neurodegeneration)
References
[Buraei Z, Yang J, The beta subunit of voltage-gated Ca2+ channels (2010)](https://pubmed.ncbi.nlm.nih.gov/20626208/)
[Dolphin AC, Calcium channel auxiliary alpha2delta and beta subunits: trafficking and one step beyond (2012)](https://pubmed.ncbi.nlm.nih.gov/22450452/)
[Bezprozvanny I, Mattson MP, Neuronal calcium mishandling and the pathogenesis of Alzheimer\'s disease (2008)](https://pubmed.ncbi.nlm.nih.gov/19651603/)
[Zamponi GW, Striessnig J, Koschak A, Dolphin AC, The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential (2015)](https://pubmed.ncbi.nlm.nih.gov/26362469/)
[Catterall WA, Voltage-gated calcium channels (2011)](https://pubmed.ncbi.nlm.nih.gov/24183073/)
[Supnet C, Bezprozvanny I, The dysregulation of intracellular calcium in Alzheimer disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20350599/)
[Surmeier DJ, Halliday GM, Simuni T, Calcium, mitochondrial dysfunction and slowing the progression of Parkinson\'s disease (2017)](https://pubmed.ncbi.nlm.nih.gov/28663134/)
[Eroglu C, Allen NJ, Susman MW, et al, Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis (2009)](https://pubmed.ncbi.nlm.nih.gov/19407815/)Pathway Diagram
The following diagram shows the key molecular relationships involving CACNB3 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)